Australia's largest stock trading and investment forum Australia's #1 stock forum

CKL

0.00%

70.5¢ colorpak limited

It is worth more than $38m or 46c, more like $60m in my book....

First 24 Last

Share
Profile

Follow
JCoure

34,208 Posts.

890

22/07/15

14:23

Post #: 15674962
Share

Originally posted by bottomfeeder1 ↑

It is interesting as we all look at what is happening on the ASX boards, but there is a lot of action off the boards that will no doubt impacting the listed businesses.

I am still convinced that Ruffy's buy of CKL was a blocking moving and maybe down the track he will merge it with PPG.

What is also worth noting is that a mid sized private packaging distributor called Silverlock was purchased by another private packaging company called Plasdene. Silverlock is a distributor of rigid and other packaging while Plasdene are mainly glass and bottle manufacturers and distributors.

Plasdene's range is predominantly built up from PGH (Pact) products. I suspect that this small consolidation play will eventually wind up into a larger consolidation of Plasdene into PPG!

What is then left is the Cospak business (Circa $120m) which is majority if not totally owned by San Miguel (The Philippine conglomerate) Their business would be decimated as they to have a significant reliance on PGH (Pact) for product.

I must say the next couple of years will be very interesting, however the level of consolidation will result in PGH and PPG owning over 95% of the rigid plastic's market (outside of Brand owners self manufacturing) Where is the ACCC????

Expand

It is worth more than $38m or 46c, more like $60m in my book. CKL will be consolidated unless, as u say, Ruffy is up to something. I do not know why Ruffy would like CKL's SP to be this low for this long. They had a poor half yearly but really. It has been dramatically oversold.

ACCC has to operate within the laws. The laws are so poor on anti-trust, you could drive a truck through them.

CKL Price at posting: 46.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga